Cargando…

Higher mortality and hospital charges in patients with cirrhosis and acute respiratory illness: a population-based study

Both cirrhosis and acute respiratory illness (ARI) carry substantial disease and financial burden. To compare hospitalized patients with cirrhosis with ARI to cirrhotic patients without ARI, a retrospective cohort study was conducted using the California Office of Statewide Health Planning and Devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Biyao, Yeo, Yee Hui, Jeong, Donghak, Sheen, Edward, Park, Haesuk, Nguyen, Pauline, Hsu, Yao-Chun, Garcia, Gabriel, Nguyen, Mindie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028654/ https://www.ncbi.nlm.nih.gov/pubmed/29967363 http://dx.doi.org/10.1038/s41598-018-28317-w

Ejemplares similares

Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis
por: Park, Haesuk, et al.
Publicado: (2018)

Mo1336: PREVALENCE AND MORTALITY OF ALCOHOL-RELATED LIVER DISEASES DURING COVID-19 PANDEMIC
por: Yeo, Yee Hui, et al.
Publicado: (2022)

County-Level Variation in Cirrhosis-Related Mortality in the US, 1999-2019
por: Ha, Audrey Y., et al.
Publicado: (2022)

Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors
por: Wong, Alina, et al.
Publicado: (2018)

Trends of Cirrhosis-related Mortality in the USA during the COVID-19 Pandemic
por: Yeo, Yee Hui, et al.
Publicado: (2023)

Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
por: Le, Michael H., et al.
Publicado: (2022)

Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
por: Ogawa, Eiichi, et al.
Publicado: (2020)

Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis
por: Wei, Bin, et al.
Publicado: (2018)

Recognizing skin conditions in patients with cirrhosis: a narrative review
por: Liu, Ying, et al.
Publicado: (2022)

Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis
por: Montano‐Loza, Aldo J., et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross‐Sectional Population‐Based Study on Its Relationship From 1999 to 2016
por: Le, Michael H., et al.
Publicado: (2019)

Gastrointestinal bleeding is associated with higher in-hospital mortality, longer length of stay and higher cost in patients with in-hospital cardiac arrest
por: Zou, Guangchen, et al.
Publicado: (2021)

Sarcopenia is the independent predictor of mortality in critically ill patients with cirrhosis
por: Khan, Saniya, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States
por: Gao, Xu, et al.
Publicado: (2022)

Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States
por: Nguyen, Vy H., et al.
Publicado: (2022)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis
por: Tran, Sally Ann, et al.
Publicado: (2018)

Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016
por: Le, Michael H., et al.
Publicado: (2020)

Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients
por: Huang, Daniel Q., et al.
Publicado: (2022)

Sex differences in disease presentation, treatment and clinical outcomes of patients with hepatocellular carcinoma: a single-centre cohort study
por: Ladenheim, Maya R, et al.
Publicado: (2016)

Obesity and mortality in critically ill COVID-19 patients with respiratory failure
por: Dana, Richard, et al.
Publicado: (2021)

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2018)

Hypoglycaemia is associated with a higher mortality in critically ill patients
por: Pereira, A Jose, et al.
Publicado: (2009)

Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
por: Lee, Hyo-Young, et al.
Publicado: (2019)

Low Alanine Aminotransferase Cut-Off for Predicting Liver Outcomes; A Nationwide Population-Based Longitudinal Cohort Study
por: Park, Jin Hwa, et al.
Publicado: (2019)

Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
por: Hoang, Joseph K., et al.
Publicado: (2016)

Disseminated intravascular coagulation score predicts mortality in critically ill patients with liver cirrhosis
por: Drolz, A, et al.
Publicado: (2015)

Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis
por: Zhang, Bing, et al.
Publicado: (2015)

Healthcare seeking behavior for respiratory illness in a northern province of Vietnam
por: Nguyen, YTT, et al.
Publicado: (2015)

Nonresponse to Interferon-α Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
por: Cozen, Myrna L., et al.
Publicado: (2013)

Higher Charges for Distant Patients
por: Lucas, Hedley
Publicado: (1921)

Higher Charges for Distant Patients?
por: Lucas, Hedley
Publicado: (1921)

Functional Capacity, Respiratory Muscle Strength, and Oxygen Consumption Predict Mortality in Patients with Cirrhosis
por: Faustini Pereira, José Leonardo, et al.
Publicado: (2016)

Clostridium difficile Infection in Liver Cirrhosis Carries a Higher Risk of Mortality: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019)

Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease
por: Chang, Christine Y., et al.
Publicado: (2017)

Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
por: Ito, Takanori, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bhqlgbu36mjd8fc0uno4gtopf0